CBD Life Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBDL research report →
About the company
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions.
- CEO
- Lisa Anne Nelson
- IPO
- 2009
- Employees
- 3
- HQ
- Scottsdale, AZ, US
Price Chart
- Market Cap
- $469.24K
- P/E
- -170.76
- P/S
- 10.61
- P/B
- 1.34
- EV/EBITDA
- -3.00
- Div Yield
- 0.00%
- Gross Margin
- -1.61%
- Op Margin
- -145.54%
- Net Margin
- -13.60%
- ROE
- -1.00%
- ROIC
- -8.40%
- Revenue
- $98.32K · -9.71%
- Net Income
- $-48,929 · 93.54%
- EPS
- $0.00 · 100.00%
- Op Income
- $-101,702
- FCF YoY
- 76.14%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3603.52
- Avg Volume
- 24.65M
Get TickerSpark's AI analysis on CBDL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CBDL coverage
Recent articles, reports, and earnings notes.
No research on CBDL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBDL report →Similar companies
Peers in the same neighborhood.